The clinical effectiveness of pegylated interferon and ribavirin for the treatment of chronic hepatitis C in HIV-infected patients in Brazil: a multicentric study (2015)
- Authors:
- USP affiliated authors: CORRÊA, MARIA CASSIA JACINTHO MENDES - FM ; MARTINELLI, ANA DE LOURDES CANDOLO - FMRP
- Unidades: FM; FMRP
- DOI: 10.1016/j.bjid.2014.08.002
- Subjects: HEPATITE C (TERAPIA); INTERFERONS; INFECÇÕES OPORTUNISTAS; HEPATITE CRÔNICA (TERAPIA); ANITIVIRAIS
- Language: Inglês
- Imprenta:
- Source:
- Título: Brazilian Journal of Infectious Diseases
- ISSN: 1413-8670
- Volume/Número/Paginação/Ano: v. 19, n. 1, p. 15-22, 2015
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
FERREIRA, Paulo Roberto Abrão et al. The clinical effectiveness of pegylated interferon and ribavirin for the treatment of chronic hepatitis C in HIV-infected patients in Brazil: a multicentric study. Brazilian Journal of Infectious Diseases, v. 19, n. 1, p. 15-22, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.bjid.2014.08.002. Acesso em: 13 fev. 2026. -
APA
Ferreira, P. R. A., Silva, M. H. da, Brandão-Melo, C. E., Rezende, R. E., Gonzalez, M., Reuter, T., et al. (2015). The clinical effectiveness of pegylated interferon and ribavirin for the treatment of chronic hepatitis C in HIV-infected patients in Brazil: a multicentric study. Brazilian Journal of Infectious Diseases, 19( 1), 15-22. doi:10.1016/j.bjid.2014.08.002 -
NLM
Ferreira PRA, Silva MH da, Brandão-Melo CE, Rezende RE, Gonzalez M, Reuter T, Urbaez JD, Gianini RJ, Martinelli A, Mendes-Corrêa MC. The clinical effectiveness of pegylated interferon and ribavirin for the treatment of chronic hepatitis C in HIV-infected patients in Brazil: a multicentric study [Internet]. Brazilian Journal of Infectious Diseases. 2015 ; 19( 1): 15-22.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1016/j.bjid.2014.08.002 -
Vancouver
Ferreira PRA, Silva MH da, Brandão-Melo CE, Rezende RE, Gonzalez M, Reuter T, Urbaez JD, Gianini RJ, Martinelli A, Mendes-Corrêa MC. The clinical effectiveness of pegylated interferon and ribavirin for the treatment of chronic hepatitis C in HIV-infected patients in Brazil: a multicentric study [Internet]. Brazilian Journal of Infectious Diseases. 2015 ; 19( 1): 15-22.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1016/j.bjid.2014.08.002 - Preliminary results from TOPAZ-III, a phase 3b study evaluating the efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir ± ribavirin in naive or experienced adults in Brazil with HCV genotype 1 infection and advanced fibrosis/cirrhosis
- Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus
- Noninvasive models for predicting liver fibrosis in individuals with hepatitis D virus/hepatitis B virus coinfection in the brazilian amazon region
- Evaluation of the utilization of filmArray meningitis/encephalitis in children with suspected central nervous system infection a retrospective case series
- Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial
- How are HCV-infected patients being identified in Brazil: a multicenter study
- Hepatitis B: prevalence and occult infection in HIV-infected patients
- Hepatitis C disease burden and strategies for elimination by 2030 in Brazil.: a mathematical modeling approach
- Contribuição para o estudo das hepatites B e C em pacientes co-infectados pelo vírus da imunodeficiência humana
- Disease burden of chronic hepatitis C in Brazil
Informações sobre o DOI: 10.1016/j.bjid.2014.08.002 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
002689240.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
